Inari Medical, Inc. (NARI)

73.07 +3.82 (+5.52%) At close: 04:00PM EDT

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 800

Key executives

Name	Title	Pay	Exercised	Year born
Mr. William H. Hoffman	CEO, Pres & Director	1.35M	4.69M	1967
Mr. Mitchell C. Hill	Chief Financial Officer	687.42k	9.79M	1959
Mr. Andrew J. Hykes	Chief Operating Officer	750.84k	4.38M	1973
Dr. Thomas M. Tu M.D.	Chief Medical Officer	752.29k	8.05M	1973
Ms. Janet Byk	VP of Fin. & Accounting	N/A	N/A	N/A
Ms. Angela Ahmad	Gen. Counsel & Sec.	N/A	N/A	N/A
Mr. Eric Khairy	VP Marketing	N/A	N/A	N/A
Mr. John R. Borrell	VP of Sales	N/A	N/A	1967

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Corporate governance

Inari Medical, Inc.’s ISS governance QualityScore as of 1 September 2022 is 8. The pillar scores are Audit: 9; Board: 8; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.